AC Immune (ACIU)
(Delayed Data from NSDQ)
$3.91 USD
0.00 (0.00%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $3.90 -0.01 (-0.26%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/2/24 |
---|---|
Current Quarter | 0.42 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -40.00% |
ABR | 1.00 |
Earnings ESP
|
71.43% |
---|---|
Current Year | -0.20 |
Next Year | 0.06 |
EPS (TTM) | -0.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 91.60M | 1.00M | 99.11M | 101.06M |
# of Estimates | 1 | 1 | 2 | 3 |
High Estimate | 91.60M | 1.00M | 99.60M | 150.76M |
Low Estimate | 91.60M | 1.00M | 98.61M | 26.82M |
Year ago Sales | 0.00M | 0.00M | 16.71M | 99.11M |
Year over Year Growth Est. | NA | NA | 493.19% | 1.97% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.42 | -0.22 | -0.20 | 0.06 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | 0.72 | -0.20 | 0.20 | 0.40 |
High Estimate | 0.77 | -0.20 | 0.20 | 0.40 |
Low Estimate | -0.23 | -0.23 | -0.92 | -0.55 |
Year ago EPS | -0.22 | -0.20 | -0.71 | -0.20 |
Year over Year Growth Est. | 290.91% | -10.00% | 71.83% | 133.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.42 | -0.22 | -0.20 | 0.06 |
7 Days Ago | 0.42 | -0.22 | -0.20 | 0.06 |
30 Days Ago | 0.44 | -0.22 | -0.20 | 0.08 |
60 Days Ago | 0.44 | -0.22 | -0.20 | 0.08 |
90 Days Ago | -0.22 | -0.21 | -0.74 | -0.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.72 | -0.20 | 0.20 | 0.40 |
Zacks Consensus Estimate | 0.42 | -0.22 | -0.20 | 0.06 |
Earnings ESP | 71.43% | 7.69% | 198.36% | 531.58% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.06 | -0.20 | -0.22 | NA |
Estimate | -0.15 | -0.07 | 0.00 | -0.22 | NA |
Difference | -0.06 | 0.01 | -0.20 | 0.00 | -0.06 |
Surprise | -40.00% | 14.29% | NA | 0.00% | -8.57% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more